Papers

1

Total Citations

4

H-Index

1

About

Dr. June Tay is a clinician-researcher whose work sits at the intersection of urological oncology and shared decision-making. Her primary research focuses on improving how patients with prostate cancer—particularly those with intermediate-risk disease—navigate the complex choice between active surveillance and radical treatment. Dr. Tay’s most cited study, a 2023 retrospective cohort analysis, evaluated the real-world utilisation and impact of the Predict Prostate prognostic model in a specialist tertiary referral centre. This work demonstrated how personalised decision-making aids can empower both clinicians and patients, providing critical insight into how such tools influence treatment choices in clinical practice. While her citation count is still growing—a reflection of her early-career stage—her research addresses a pressing need in modern oncology: balancing evidence-based medicine with patient values. Dr. Tay’s contributions are particularly notable for bridging the gap between computational risk prediction and bedside communication, offering a practical framework for integrating decision aids into routine care. Her work is essential reading for anyone interested in precision medicine, patient-centred care, and the real-world translation of predictive models.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Utilisation and impact of predict prostate on decision‐making among clinicians and patients in a specialist tertiary referral centre: A retrospective cohort study
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Cambridge University Hospitals NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago